Australia's largest stock trading and investment forum Australia's #1 stock forum

SPL

0.00%

9.7¢ starpharma holdings limited

Ann: VivaGel BV phase 3 trials for prevention of BV completed, page-22

First 22 Last

Share
Profile

Follow
mukesh2001

752 Posts.

01/04/17

11:30

Post #: 23787660
Share

Originally posted by colin037 ↑

In 1981 a company called COCHLEAR was launched, this is my Cochlear, it took till 1999 to reach a share
price of $8.60, eighteen years!.
If buyers had listened to people like you, there would be a lot of people tearing their hair out today with the company share price @ $135.00.
I've held since 2002, that's patience for you!.

Expand

Happy birthday... welcome to the world... btw which one of the 2 are you???

SPL Price at posting: 67.0¢ Sentiment: Sell Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 10 more messages in this thread...

First 22 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.7¢		Change 0.000(0.00%)		Mkt cap ! $40.48M

Open	High	Low	Value	Volume
9.9¢	9.9¢	9.5¢	$35.24K	364.0K

Buyers (Bids)

No.	Vol.	Price($)
3	18326	9.5¢

Sellers (Offers)

Price($)	Vol.	No.
9.8¢	15262	2

View Market Depth

No.	Vol.	Price($)
2	8326	0.095
3	160000	0.094
2	134306	0.092
3	81442	0.090
1	30000	0.089

Price($)	Vol.	No.
0.098	5000	1
0.100	38876	3
0.105	199768	2
0.110	168286	9
0.115	85453	2

Last trade - 16.10pm 04/10/2024 (20 minute delay)

SPL (ASX) Chart

Ann: VivaGel BV phase 3 trials for prevention of BV completed, page-22

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: VivaGel BV phase 3 trials for prevention of BV completed, page-22

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News